InvestorsHub Logo
Followers 2
Posts 385
Boards Moderated 0
Alias Born 09/20/2017

Re: None

Tuesday, 09/11/2018 12:07:49 PM

Tuesday, September 11, 2018 12:07:49 PM

Post# of 3987
I think the PRX-102 price will depend on P3 trials results. If the superiority is confirmed and the medicine may be recognized as the gold standard therapy PRX-102 price IMO will be higher than Fabrazyme maybe somewhere within $250-270 thousand.Anyway, I hope that Protalix and Chiesi will solve the issue of price better than it once did Pfizer for Elelyso.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News